7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Non-Classical Monocytes Predict Progression of Carotid Artery Bifurcation Intima-Media Thickness in HIV-infected Individuals on Stable Antiretroviral Therapy

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          BACKGROUND

          Inflammation may contribute to cardiovascular disease (CVD) among antiretrovirally suppressed HIV-infected individuals. We assessed relationships of monocyte, CD8 T-cell activation and plasma biomarkers to changes in carotid artery intima-media thickness (CIMT).

          METHODS

          Longitudinal study of HIV-infected subjects ≥ 40 years and on stable antiretroviral therapy (ART) ≥ 3 months. Peripheral blood mononuclear cells were immunophenotyped by multiparameteric flow cytometry to quantify classical (CD14 ++CD16 ), intermediate (CD14 ++CD16 +), non-classical (CD14 low/+CD16 ++) and transitional (CD14+CD16−) monocyte subsets and activated (CD38 +HLA-DR +) CD8 + T-cells at baseline. Plasma biomarkers were assessed by multiplex Luminex assay. High resolution B-mode ultrasounds of right carotid arteries were obtained. Changes in CIMT over 2 years at the right common carotid artery (CIMT CCA) and right bifurcation (CIMT BIF) were outcome variables.

          RESULTS

          We studied 50 subjects: 84% male, median age 49 (Q1, Q3; 46, 56) years, median CD4 count 461 (317, 578) cells/mm 3, and with HIV RNA≤50 copies/mL in 84%. Change in CIMT BIF correlated with log values of baseline absolute count of non-classical monocytes (r=0.37, p=0.020), and with MCP-1 (r=0.42, p=0.0024) and TNF-α (r=0.30, p=0.036) levels. In multivariable linear regression, only non-classical monocytes and MCP-1 predicted the change in CIMT BIF, independent of Framingham Risk Score and baseline CIMT BIF. No correlation was noted between CD8 T-cell activation and CIMT BIF change. Monocyte subsets, CD8 T-cell activation and biomarker concentrations were not correlated with changes in CIMT CCA.

          CONCLUSIONS

          Our findings highlight the role of non-classical monocytes and MCP-1 in the progression of CIMT BIF in HIV-infected individuals on stable ART independent of traditional cardio-metabolic risk factors.

          Related collections

          Author and article information

          Journal
          100936377
          26735
          HIV Clin Trials
          HIV Clin Trials
          HIV clinical trials
          1528-4336
          1945-5771
          21 May 2016
          04 April 2016
          May 2016
          01 May 2017
          : 17
          : 3
          : 114-122
          Affiliations
          [1 ]University of Hawaii, Honolulu, Hawaii, USA
          [2 ]Queen’s Medical Center, Honolulu, Hawaii, USA
          [3 ]University of Southern California Atherosclerosis Research Unit, CA, USA
          [4 ]Straub Medical Center, Honolulu, Hawaii, USA
          [5 ]Blood Systems Research Institute, San Francisco, CA
          [6 ]Department of Laboratory Medicine, University of California, San Francisco, CA
          [7 ]Department of Medicine, University of California, San Francisco, CA
          Author notes
          Corresponding Author: Dominic Chow, MD, PhD, MPH, Professor of Medicine, Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawaii at Manoa, 651 Ilalo St., Biomedical Sciences Building 231, Honolulu, HI 96813, Ph: (808) 692-1310, Fax: (808) 692-1345, dominicc@ 123456hawaii.edu
          Article
          PMC4892178 PMC4892178 4892178 nihpa788088
          10.1080/15284336.2016.1162386
          4892178
          27125366
          70fcc5fa-64dd-404c-a33a-eefc89a0678e
          History
          Categories
          Article

          Biomarkers,Monocytes,cIMT,HIV
          Biomarkers, Monocytes, cIMT, HIV

          Comments

          Comment on this article